Chemoprevention of head and neck cancer

被引：4

作者：

Katrina Y. Glover

Vali A. Papadimitrakopoulou

机构：

[1] Dept. Thorac./Head/Neck Med. Oncol., University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030

来源：

Current Oncology Reports | 2003年 / 5卷 / 2期

关键词：

Epidermal Growth Factor Receptor; Neck Cancer; Aerodigestive Tract; Premalignant Lesion; Etretinate;

D O I：

10.1007/s11912-003-0103-x

中图分类号：

学科分类号：

摘要：

Squamous cell carcinoma of the head and neck is the most common epithelial neoplasm of the upper aerodigestive tract and represents a major health concern in the United States and worldwide. Invasive squamous cell carcinoma is the end result of a multiyear, multistep process of accumulation of genetic and phenotypic damage. Chemoprevention is defined as the use of pharmacologic or natural agents that inhibit the development of invasive cancer whether by blocking the DNA damage that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has already occurred. Chemoprevention is widely recognized as an important area of research in head and neck cancer. This article reviews the field of chemoprevention and recent advances in molecular epidemiology and genetics. Current clinical trials are described. Copyright © 2003 by Current Science Inc.

引用

页码：152 / 157

页数：5

共 55 条

[1]

Jemal A., Thomas A., Murray T., Thun M., Cancer statistics 2002, CA Cancer J. Clin., 52, pp. 23-47, (2002)

[2]

Mashberg A., Re: Oral cavity cancer in non-users of tobacco, J. Natl. Cancer Inst., 85, (1993)

[3]

Vokes E.E., Weichselbaum R.R., Lippman S.M., Et al., Head and neck cancer, N. Engl. J. Med., 328, pp. 184-194, (1993)

[4]

Cooper J.S., Pajak T.F., Rubin P., Et al., Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience, Int. J. Radiat. Oncol. Biol. Phys., 17, pp. 449-456, (1989)

[5]

Lippman S.M., Spitz M., Trizna Z., Et al., Epidemiology, biology, and chemoprevention of aerodigestive cancer, Cancer, 74, SUPPL., pp. 2719-2725, (1994)

[6]

Jones A.S., Morar P., Phillips D.E., Et al., Second primary tumors in patients with head and neck squamous cell carcinoma, Cancer, 75, pp. 1343-1353, (1995)

[7]

Lippman S.M., Hong W.K., Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease, Int. J. Radiat. Oncol. Biol. Phys., 17, pp. 691-694, (1989)

[8]

Sporn M.B., Dunlop N.M., Newton D.L., Smith J.M., Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids), Fed. Proc., 35, pp. 1332-1338, (1976)

[9]

Hong W.K., Sporn M.B., Recent advances in chemoprevention of cancer, Science, 278, pp. 1073-1077, (1997)

[10]

Rothman K.J., Cann C.I., Flanders D., Fried M.P., Epidemiology of laryngeal cancer, Epidemiol. Rev., 2, pp. 195-209, (1980)

← 1 2 3 4 5 6 →